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An in vitro colony-forming assay and flow cytometry were used
to identify rat hepatoblasts as being classical MHC class I, RT1Al-,
OX18low intercellular adhesion molecule 1 (ICAM-1)1. Inducible dif-
ferentiation toward biliary lineage was observed in most colonies
derived from single RT1Al- progenitors, proving their bipotentiality.
These findings demonstrate the antigenic profile of clonogenic hepa-
toblasts and proof of their bipotency. Furthermore, whereas colony
formation of adult hepatocytes required epidermal growth factor,
clonal growth of hepatoblasts was potentiated without epider-
mal growth factor. The adult hepatic colonies consisted of
RT1Al1OX181ICAM-111 cells. These results indicate that hepatoblasts
possess unique characteristics as compared with adult hepatocytes
harboring significant proliferative activity. The phenotypic identity of
hepatoblasts and the clonal culture system have relevance for iden-
tifying hepatic stem cells from adults, for studying liver development,
and for cell therapy based on hepatic progenitors.
Identification of multipotential progenitor populations in mam-malian tissues is important both for therapeutic potential and
an understanding of developmental processes and tissue ho-
meostasis. Progenitor populations are ideal targets for gene
therapy, cell transplantation, and tissue engineering of bioarti-
ficial organs (1, 2). A demand for liver progenitors is increasing
because of a severe shortage of donor organs for orthotopic liver
transplantation. Because liver transplantation currently is the
only successful therapy for patients suffering chronic liver fail-
ure, cell therapy with hepatic progenitors offers an alternative
approach for therapies of liver diseases.
In the context of liver development, hepatic cells in the early
fetal liver are designated as hepatoblasts. These are bipotent
progenitors that give rise to hepatocytic and biliary lineages of
cells (3, 4). As early as embryonic day (E) 13 in rat, hepatic
progenitors are thought to be a homogeneous population with
developmentally equal bipotentiality (4). However, direct evi-
dence for bipotency of these progenitors has not yet been shown.
Moreover, because the antigenic identity of hepatoblasts has not
been determined, neither clonal identification nor purification of
hepatoblasts for clonal analyses has been possible.
The mammalian adult liver has a tremendous capacity to
recover after either extensive hepatotoxic injury or partial
hepatectomy (5). Data from recent studies in the mouse have
been interpreted to suggest that some medium- to large-sized
(21–27 mm) hepatocytes from adults have an extensive growth
potential as assayed by transplantation experiments (6). How-
ever, no evidence has been suggested for biliary epithelial
differentiation in the transgenic mouse system (6). On the other
hand, recent in vitro studies indicated that small adult hepato-
cytes (less than 20 mm) demonstrate higher growth potential
than that of larger hepatocytes (7). Even though physiological
significance of these subpopulations in normal liver turnover
remains controversial, it is suggested that in vivo repopulatable
hepatocytes and in vitro highly proliferative hepatocytes are
different subpopulations based on the size fractionation (6, 7).
Moreover, the relevance of progenitors to either in vivo or in vitro
growth is uncertain, especially because it is unknown whether
hepatoblasts are conserved as progenitors in adult livers.
Materials and Methods
Rats. Pregnant Fisher 344 rats were obtained from the Charles
River Breeding Laboratories. The morning on which the plug
was observed was designated day 0. Male Fisher 344 rats
(200–250 g) were used for adult liver cells. All animal experi-
ments have been conducted in accordance with institutional
guidelines.
Cell Preparation. E13 fetal livers were digested with 800 unitsyml
collagenase (Sigma) and 20 unitsyml thermolysin (Sigma) followed
by further digestion with trypsin-EDTA solution (Sigma). The cell
suspension was treated with 200 unitsyml DNase I (Sigma). Adult
liver cells were obtained by a two-step liver perfusion method as
described (8). After perfusion, the cells were filtrated with a 30-mm
sieve to remove large aggregated cells. Cellular viability was .90%
as measured by trypan blue exclusion.
Hepatic Cell Lines and Cell Culture. Several hepatic cell lines were
established from E15 fetal liver on STO (American Type Culture
Collection) feeders and in a serum-free hormonally defined
medium (HDM), as described in detail in the supplemental
material, which is published on the PNAS website, www.pnas.
org. The HDM was developed based on other serum-free media
(9–11). STO feeder cells were prepared as described (12). The
cell adhesion assays for hepatic cell lines and the description of
the isolation of STO sublines and STO5 cells transfected with
pEF-Hlx-MC1neo [a kind gift from J. M. Adams, The Walter
and Eliza Hall Institute of Medical Research, Melbourne, Aus-
tralia (13)] are described in the supplemental materials.
Immunohistochemical Staining of Colonies. Culture plates were
fixed in methanol-acetone (1:1) for 2 min at room temperature,
rinsed, and blocked with 20% goat serum (GIBCOyBRL) at 4°C.
For double labeling of a-fetoprotein (AFP) and albumin (ALB),
plates were incubated with anti-rat ALB antibody (ICN) fol-
lowed by Texas Red-conjugated anti-rabbit IgG (Vector Labo-
ratories) and FITC-conjugated anti-rat AFP polyclonal antibody
(Nordic, Immunological Laboratories, Tilburg, The Nether-
Abbreviations: CFA, colony-forming assay; E(n), embryonic day; AFP, a-fetoprotein; ALB,
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lands). For double labeling of ALB and cytokeratin (CK) 19,
anti-CK19 mAb (Amersham Pharmacia) and FITC-conjugated
anti-mouse IgG (Caltag, South San Francisco, CA) were used.
Flow Cytometric Analysis. Cells stained with mAbs were analyzed
on a FACScan (Becton Dickinson) or sorted by using a Moflow
(Cytomation, Fort Collins, CO). After blocking with 20% goat
serum and 1% teleostean gelatin (Sigma), hepatic cell lines and
adult liver cells were stained with FITC-conjugated anti-
RT1Aa,b,l B5 (PharMingen), anti-RT1A OX18 (PharMingen),
phycoerythrin (PE)-conjugated anti-rat intercellular adhesion
molecule 1 (ICAM-1) 1A29 (PharMingen) or FITC-conjugated
anti-rat integrin b1 Ha2y5 (PharMingen). FITC-conjugated anti-
mouse IgG was used for OX18. Cell suspensions of the hepatic
cell lines or freshly isolated cells cultured on STO feeders were
stained with biotinilated anti-mouse CD98 (PharMingen) fol-
lowed by a second staining with streptavidin-RED670 (GIBCOy
BRL) as well as anti-rat mAbs to gate out mouse STO cells. The
cells from E13 fetal liver were stained with FITC-B5, PE-1A29,
and biotinylated OX18 followed by streptavidin-RED670 for
three-color staining.
Colony-Forming Assay (CFA) for Hepatic Cell Lines, Sorted Cells, and
Adult Liver Cells. The hepatic cell lines were plated in triplicate at
500 cellsy9.6 cm2 on STO feeders and in HDM. The cultures
were incubated for 10–14 days with medium changes every other
day. Double immunofluorescence staining of AFP and ALB
then was performed. One hundred colonies per well were
analyzed in the colony morphology and for the expression of
AFP and ALB. The colonies were stained by Diff-Quik (Dade,
Düdingen, Switzerland) to count the number of colonies per
well. As another minor modification in the CFA for freshly
isolated cells, the plating cell number was changed as described
in Results; the culture period was expanded to 14–17 days; the
concentration of dexamethasone and epidermal growth factor
(EGF) was changed to 10-6 M and 10 ngyml respectively. For
CFA of biliary differentiation, double staining of ALB and CK19
of the colonies was performed at 5-day intervals of the culture
in the presence or absence of EGF. At day 5 of the cultures, a
colony with more than one CK191 cell was counted as a CK191
colony. At days 10 and 15, a colony containing multiple clusters
of two CK191 cells or one cluster of more than three CK191 cells
was counted as a CK191 colony. Each point represents the
mean 6 SD from triplicate-stained cultures. In the CFA for adult
liver cells, small clumps of liver cells could not be eliminated by
the regular preparation. Therefore, an undefined number of the
colonies might be produced from the clumps.
Results
Establishment of a CFA for Hepatic Progenitors. Although a number
of defined culture conditions have been developed for hepatic
cells (9, 11, 14), none supports the growth of liver cells at
sufficiently low density to permit true clonal analysis. To develop
an in vitro CFA system for identification of clonogenic hepato-
blasts necessitates culture conditions that support the growth of
a single cell to a colony and in which cell expansion is associated
with retention of the phenotypic characteristics of the cell of
origin. Hepatic cell lines were used initially as models for hepatic
progenitors. Several hepatic cell lines from rat fetal livers were
established on feeders of a STO embryonic cell line and in HDM.
Rhel4321 consisted mostly of packed or aggregated small cells,
whereas th1120–3 made only flattened monolayers (Fig. 1 A
a–d). Rter6 produced aggregate clusters and flattened mono-
layers constantly even after repetitive cloning. In addition to the
morphological difference in the three cell lines, they had differ-
ent adhesive affinity to specific components of extracellular
matrices. Whereas collagen type IV was the most effective in the
attachment of th1120–3, similar to the findings for the adult liver
Fig. 1. Comparative characterization of hepatic cell lines. (A) Phase contrast and the immunofluorescence micrograph of rhel4321 (a and b), th1120–6 (c and
d), and rter6 (e–g) are presented. Rhel4321 (b) and th1120–6 (d) were labeled with anti-AFP. Rter6 was doubly labeled with Abs for AFP ( f) and ALB (g). Original
magnifications: a–d, 3200; e–g, 3100. (B) Cell adhesion assay. Each cell line was cultured in microtiter wells coated with laminin (F), fibronectin (h), or collagen
IV (‚). The number of adherent cells was measured. CFA of rter6 (C and E) and rhel4321 (D and F). The degrees of AFP and ALB expression were divided into four
ranges: 11 (90–100% of cells are positive), 1 (10–90%), 6 (1–10%), and 2 (0%). Blank column represents only the types of the colonies. x axis indicates colony
number (C and D) or aggregated colony number (E and F) per 100 colonies. Data shown represent the means 6 SD of triplicates.














cells (15), it worked less well for rter6 and rhel4321 (Fig. 1B).
Laminin proved the most effective substratum for adhesion of
rhel4321 (Fig. 1B). The preference to laminin rather than
fibronectin or collagen type IV in rhel4321 is similar to that of
fetal hepatic cells (15). Using these cell lines, a systematic CFA
was developed. When rter6 was cultured on the feeders at a
seeding density of 52 cellsycm2, the cell line produced two types
of colonies. In Fig. 1 Ae, the left colony consisted of aggregated
small cells (type I colony), whereas the other colony at the right
produced a flattened monolayer (type II colony). Double im-
munostaining of AFP and ALB, phenotypic markers for early
hepatic progenitors, indicated that intense expression of both
AFP and ALB was observed only in type I colonies (Fig. 1 A f and
g). These results indicate that this culture condition can support
the growth of a single cell to a colony maintaining the phenotypic
characteristics of early hepatic progenitors. Furthermore, STO
subclones were compared in their ability to support aggregated
colonies because almost all type I colonies of rter6 and rhel4321
strongly expressed AFP, whereas type II colonies of cells did not
(Fig. 1 C and D). One of the clones, STO5, supported the colony
formation more than any of the other sublines and more than the
parent line (Fig. 1 E and F). Therefore, STO5 was used for clonal
analysis of primary hepatic cells, because the culture conditions
yielding the highest production of type I colonies were assured
to be the best for clonal assays for freshly isolated hepatic
progenitors.
Surface Antigenic Profiles of the Hepatic Cell Lines. The antigenic
profiles of the two hepatic cell lines and freshly isolated adult
liver cells were characterized. Compared with adult hepatocytes
and rter6, the antigenic profile of the rhel4321 is quite unique in
that there is no expression of RT1Al, rat classical MHC class I
in the Fisher 344 strain, and fairly low signals identifiable by mAb
OX18, which recognizes nonpolymorphic MHC class I antigens
(Fig. 2). The pattern of the ICAM-1 expression in rhel4321 is
heterogeneous, whereas integrin b1 was expressed uniformly in
the line.
Clonal Identification of Hepatic Progenitors in Fetal Livers. Hepato-
genesis and massive amounts of hematopoiesis coexist in the
fetal liver. Because adult bone marrow cells other than mature
erythrocytes strongly express MHC class I molecules (data not
shown), it was expected that the fetal hepatic population could
be separated effectively from the hematopoietic cell populations
by MHC class I expression. The cell suspensions from rat E13
livers were stained with MHC class I, ICAM-1, and integrin b1
mAbs. The two-color staining pattern of RT1Al and ICAM-1
showed several populations (Fig. 3A), whereas integrin b1 was
expressed uniformly in most of the cells (data not shown). To
determine which population contained the hepatic cells, five
fractions were isolated by flow cytometric sorts and then
screened by the CFA. Fig. 3B represents the result of resorting
of the five sorted fractions (gates 1–5). The hepatic cell colonies,
defined by expression of ALB and AFP, were also distinguish-
able morphologically (Fig. 3C), enabling one to count the
number of hepatic colonies per well. The majority of the hepatic
colonies were detected in gate 2 (Table 1). A small number of
Fig. 2. Surface phenotypes of hepatic cell lines (rhel4321 and rter6) and adult
hepatocytes. They were stained with mAbs anti-RT1Al, OX18, anti-ICAM-1, or
anti-integrin b1 (closed histogram). The cell number is plotted versus log10 of
the mean fluorescence intensity. The solid line indicates the unstained cells or
secondary antibody alone.
Fig. 3. Phenotypic analysis of E13 rat fetal livers. (A) Cells were stained with anti-RT1Al and anti-ICAM-1 mAbs. Unstained cell suspension is indicated for
negative control. (B) After cell sorting, the collected cells of five fractions (1–5 on the upper left column) based on the expression of RT1Al and ICAM-1 were
resorted. Each fractionated cell population was cultured for the CFA (Table 1). (C) Immunofluorescence labeling of hepatic colonies with Abs for AFP (b and e)
and ALB (c and f ) are shown with corresponding phase contrast fields (a and d). d–f represent a part of a large colony. Original magnification: 3200. (D) Cells
were stained with anti-RT1Al, anti-ICAM-1, and anti-OX18. Two gates (R1 and R2) were created with respect to differences in side scatter. The cells included in
each gate were analyzed with respect to their expression of RT1Al and ICAM-1. The histogram (E) represents the expression of OX18 in each gate (R3–R6) of D.
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the colonies appeared in gate 1. The other fractions contained
negligible numbers of cells with hepatic colony-forming ability.
Evidently the culture conditions supported clonal expansion of
hepatic colonies without loss of the expression of AFP and ALB
(Fig. 3C). To investigate the MHC class I expression on the
hepatic cells in detail, three-color staining of RT1Al, ICAM-1,
and OX18 with the side scatter (SSC), a reflection of the
granularity of cell, as another parameter, were used for the cell
fractionation (R1 and R2). Fig. 3D shows that the cells in gate
2 (Fig. 3B) derived from the R2 gate exclusively. Gating R2 based
on the SSC, the population corresponding to the gate 2, clearly
showed RT1Al- and OX18low phenotype (Fig. 3 D and E). The
CFA of these cells confirmed that R4, but not R3, harbors
colony-forming cells (Table 1). These results suggest that the
RT1Al-OX18lowICAM-11 population from E13 rat liver consists
of hepatic progenitors.
Evidence for Bipotentiality in the Clonogenic Hepatic Progenitors. At
E13 of gestation in the rat, the hepatic cells have a develop-
mental potential, giving rise to mature hepatocytes and bile duct
epithelium, even though they express no markers for the biliary
lineage (4). If the identified hepatic progenitors are bipotent, the
fate of biliary lineage could be dictated under distinct culture
conditions. To test the hypothesis, the sorted RT1Al-
OX18lowICAM-11 cells were cultured in the presence or absence
of EGF followed by the double immunostaining of CK19 and
ALB for the colonies to monitor their fates at 5-day intervals.
CK19 is one of the most remarkable markers for biliary
epithelial cells in adult liver, because hepatocytes don’t express
CK19 at all (16). However, CK19 can’t be detected during
hepatic development before E15 in the rat fetus (4). As devel-
opment progresses, maturing bile ducts gradually lose the ex-
pression of ALB (4). Therefore, the induction of the expression
of CK19 and the disappearance of the ALB expression can be
used as the indicator for initial development of a biliary
phenotype.
After the first 5 days, the CK191 colonies were negligible in
the cultures treated with EGF, whereas a few colonies contain-
ing CK191 cells occurred in the absence of EGF (Fig. 4A).
Although the intensity of the CK19 expression was fairly weak,
the CK191 cells showed reduced ALB expression. At the 10th
day of the culture, some of the colonies contained only CK191
cells or ALB1 cells, and others had both of them (Fig. 4A). In
the majority of colonies in the presence of EGF, CK19 expres-
sion was not induced at the 10th day of the culture. In the absence
of EGF, most of the colonies contained CK191 cells by day 15
of culture (Fig. 4A), although the number of CK191 cells in a
single colony varied among the colonies. The pattern of the
CK191 and ALB1 cells in a single colony, as shown in Fig. 4B,
was reciprocal. Some of the colonies, however, consisted of cells
coexpressing ALB and CK19 (data not shown). Furthermore,
the results of single-cell analysis designed by single-cell culture
Table 1. The frequency of hepatic colonies from sorted fetal liver cells
Experiment
Inoculated cell number Hepatic colony number Colony efficiency, %
I II III I II III I II III
Gate 1 500 500 500 19 28 8.7 3.8 5.7 1.7
Gate 2 500 500 500 88 99 136 17.7 19.9 27.3
Gate 3 500 5,000 5,000 0.7 8 10 0.1 0.2 0.2
Gate 4 500 5,000 5,000 0 2.3 6.3 0 0.1 0.1
Gate 5 500 5,000 5,000 0.3 1.7 5 0.1 0 0.1
IV V VI IV V VI IV V VI
R3 500 500 1,000 1 3.7 7 0.2 0.7 0.7
R4 500 500 500 176 167 269 35.2 33.4 53.9
Flow cytometric sorted cells from each fraction in Fig. 3 were cultured on feeders at indicated cell number per
well (9.6 cm2). The hepatic colony number (per well) was given from triplicate-stained cultures (mean). Colony
efficiency is expressed as the percentage of cells inoculated in culture that went on to form colonies after 16 days
of the culture. Results of six independent experiments are shown.
Fig. 4. Bipotency of differentiation of multiparametric sorted hepatic pro-
genitors. (A) Cells were fixed at 5-day intervals after starting the culture in the
presence or absence of EGF and stained for ALB and CK19, and the proportion
of the types of colonies was determined. ■, Œ, and v represent the colonies
containing ALB1 cells and CK191 cells, only ALB1 cells, and only CK191 cells,
respectively. Data shown represent the means 6 SD of triplicates. (B) The
bipotent nature of a single RT1Al- hepatic progenitor. The hepatic progenitors
were cultured at 52 cellsycm2 in the absence of EGF. A single cell was selected
as shown by an arrow and was monitored for colony formation. Scratches at
the top and the right in each field were made on the bottom surface of the
culture plate by a needle. Phase contrast images of the culture at 24 h (a), day
2 (b), day 3 (c), day 4 (d), day 6 (e), day 7 ( f), day 8 (g), day 9 (h), day 11 (i), and
day 12 (j) after plating are shown. After 12 days of culture, the colony was
double-stained for ALB and CK19. The merged immunofluorescence image (k)
of ALB (red) and CK19 (green) corresponds to that shown in phase contrast (j).
All magnifications are the same as a. (Bar 5 100 mm.)














(Table 2) and serial observation of colony formation from single
cells followed by staining for ALB and CK19 (Fig. 4B) demon-
strated the clonogenic bipotent nature of the isolated RT1Al-
cells. Collectively, the RT1Al-OX18lowICAM-11 cells from E13
fetal liver are bipotent hepatic progenitors, hepatoblasts, with
heterogeneous response to inductive cues for biliary lineage.
Comparative Analysis of Hepatoblasts and Highly Proliferative Hepa-
tocytes. It was unknown whether or not highly proliferative
hepatocytes in adult liver conserve any antigenic or character-
istic phenotypes of hepatoblasts in early fetal liver. The colony
formation, morphology, and ex vivo growth requirements as well
as proliferative capability of sorted hepatoblasts were compared
with that of colonies of hepatocytes from adult liver by using the
defined feeders and the HDM. As shown in Fig. 5A, the colony
size of the hepatoblasts increased in the absence of EGF,
whereas adult hepatocytes yielded large colonies only in the
presence of EGF (Fig. 5B). The morphology of the colonies
derived from adult liver cells was the flattened monolayer with
the modest expression of AFP and ALB (Fig. 5C). After over 2
weeks of culture, the expression of RT1Al, OX18, and ICAM-1
was assessed. As shown in Fig. 5D, the expression of RT1Al,
OX18, and ICAM-1 did not change in the culture of hepato-
blasts. On the other hand, the expression of RT1Al and OX18 in
the highly proliferative hepatocytes from adult liver was clearly
positive. Whereas the antigenic profiles of either freshly isolated
or cultured hepatocytes in adults is RT1Al1OX181ICAM-11,
the expression of ICAM-1 was induced intensively in colony-
forming cells in culture relative to that of freshly isolated cells
(Figs. 2 and 5D). EGF did not affect the expression of MHC class
I expression (data not shown). Furthermore, the average cell
number in a single colony was calculated from the recovered cell
number, the percentage of rat hepatic cells, and the colony
efficiency. The estimated cell number in colonies from hepato-
blasts reached 3–4 3 103 cells, whereas that from adult hepa-
tocytes was 130 cells on average, indicating less growth potential
under the conditions used (Table 3, which is published as
supplemental material).
Discussion
The antigenic profile of hepatoblasts in E13 rat liver has been
found to be RT1Al-OX18lowICAM-11. Because no other cellular
subpopulation showed such significant numbers of hepatic col-
onies in the assay, it is suggested that this antigenic profile is that
for the earliest cells in the rat hepatic lineage. So far, all hepatic
cells as early as E13 in the rat are thought to be a homogeneous
population and able to differentiate to biliary epithelial cell
lineage as well as to mature hepatocytes. A clonal culture system
established in this study allowed the growth of hepatic cells at
sufficiently low density and high efficiency of colony formation
to perform definitive clonal analysis for specific cellular sub-
populations in the fetal liver. The data in which most colonies
from single RT1Al-OX18lowICAM-11 cells contained some de-
scendents having a biliary phenotype supports the hypothesis.
The clonal assay, however, clearly showed that the response to
inductive cues for biliary lineage is different in subpopulations of
hepatic progenitors. Some of them quickly lose the expression of
ALB and begin CK19 expression (Fig. 4A). In addition, the
clonal culture conditions were able to modify their fates. The
stromal factors from STO cells in the absence or presence of

















I Single-cell culture 1 192 61 32 92
CFA 420 3 394* 31 96
II Single-cell culture 1 192 31 16 97
CFA 500 3 220* 15 95
Sorted hepatic progenitor cells were cultured on feeders in four 48-well plates at one cell per well in the
absence of EGF. A standard CFA was performed for a comparative analysis. After 15 days of the culture, hepatic
colonies were doubly stained for ALB and CK19. All colonies contained ALB1 cells, and the proportion of colonies
also containing CK191 cells among the hepatic colonies are indicated above. The total number of the colonies was
counted after visible dye staining.
*Colony number of CFA was combined from triplicate-stained cultures.
Fig. 5. Comparative analysis of hepatoblasts and highly proliferative hepa-
tocytes. (A) Hepatoblasts from E13 liver or adult liver cells were cultured on
STO feeders for 16 days then stained with Diff-Quik. (B) The colony number in
the culture with or without EGF. The number of the hepatic colonies per well
was counted from triplicate cultures. Data shown represent the means 6 SD
of triplicates. (C) Hepatic colony from adult liver (a–c). The micrographs of the
phase contrast (a) and the double labeling with anti-AFP (b) and anti-ALB (c)
are shown. Original magnification: 3200. (D) The surface analysis of cultured
hepatoblasts and adult liver cells. Cultured cells were stained with mAbs,
anti-RT1Al, OX18, or anti-ICAM-1. Mouse CD98 negative population represent
rat cells.
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EGF are good candidates for eliciting specific fate determina-
tion, because it is speculated that the mesenchymal factors from
the connective tissue surrounding the portal vein are important
for biliary differentiation (17).
Furthermore, the culture system based on STO feeders and
HDM detected a subpopulation of adult liver cells that are highly
proliferative even at clonal densities. There are three remarkable
differences between hepatoblasts and these highly proliferative
hepatocytes. First, the hepatocytes express RT1Al (Fig. 5C).
Second, the hepatocytes produce flattened colonies, whereas
colonies from hepatoblasts are aggregates consisting of small
cells during the primary expansion (Figs. 3C and 5C). Third, the
growth of the highly proliferative hepatocytes is dramatically
reduced in the absence of EGF, whereas the clonal growth of
hepatoblasts is potentiated in the absence of EGF (Fig. 5 A and
B). Moreover, the magnitude of ex vivo proliferation capability
is more potent in hepatoblasts under the clonal culture condi-
tions (Table 3). Although neither RT1Al- cells nor aggregated
colonies were observed with or without EGF in adult liver cell
cultures, it remains to be determined whether or not counter-
parts of hepatoblasts exist in the adult liver given the method of
isolation or cultivation of the adult cells.
Laboratory rats other than those with the RT1c haplotype
possess only one functional classical MHC class I locus (18).
Therefore, the data indicating an absence of surface expression
of RT1Al on R4 cell fraction (Fig. 3D) mean that rat hepatoblasts
do not express classical MHC class I on the cell surface. There
are typically two groups of MHC class I antigens, classical MHC
class I and nonclassical MHC class I (MHC class Ib). Classical
MHC class I performs a critical role in immune surveillance,
according to present exogenous antigens at the cell surface to
antigen-specific ab T cell receptors on CD8 T lymphocytes,
whereas most of MHC class Ib have yet to be assigned a function.
The weak positive signal by OX18 on the hepatoblasts (Fig. 3E)
suggests that they express certain MHC class Ib antigens, e.g.,
mouse Q10, the expression pattern of which is similar to that of
serum proteins such as ALB and AFP (19). Furthermore, it is
well documented that undifferentiated pluripotent teratocarti-
nomas tightly suppress the expression of classical MHC class I
but do not suppress a few of the MHC class Ib genes (20). The
expression of classical MHC class I is induced after differenti-
ation (21). Therefore, classical MHC class I expression is one of
the developmentally controlled antigens. This is the case in the
hepatic lineage also. Here, the developmental heterogeneity has
been established clearly in the hepatic lineage.
As classical MHC class I genes are highly polymorphic (22),
they also provoke a strong allograft response. The highly pro-
liferative hepatocytes after ex vivo expansion induced an intense
expression of ICAM-1 expression in addition to the MHC class
I expression, whereas hepatoblasts retained the original pheno-
type (Fig. 5D). Peptide-MHC complex and ICAM-1 antigens are
crucial molecules for the formation of the ‘‘immunological
synapse,’’ a specialized junction between a T cell and a target cell
(23). Therefore, ex vivo expanded hepatoblasts and hepatocytes
should be different in the context of immunological recognition
by CD8 T cells. The unique phenotype of undetectable expres-
sion of classical MHC class I and lower expression of ICAM-1
on the hepatoblasts might be advantageous and be relied on for
the escape from the host immune system when they are trans-
planted in an MHC incompatible host.
Further characterization of identified clonogenic hepatoblasts
and use of the CFA system will be important for clinical
therapies based on hepatic progenitors. Interestingly, a previous
immunohistochemical study suggests that the developing human
hepatic cells in fetuses express only MHC class Ib antigens, but
not classical MHC class I antigens (24). If the human hepatic
progenitors have a similar unique phenotype to that of rat
hepatoblasts in terms of no classical MHC class I and modest
ICAM-1 expression, are bipotential with respect to biliary and
hepatocytic lineages, and have potent growth capability, this
progenitor population should have great promise for nonauto-
logous cell transplantation, ex vivo gene therapy, or bioartificial
liver devices.
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